Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene.

Cancer - 1 Nov 2012

Xu Bin, Zheng Wen-Yan, Jin Da-Yong, Wang Dan-Song, Liu Xin-Yuan, Qin Xin-Yu

Abstract excerpt

BACKGROUND: The 5-year survival rate for patients with pancreatic cancer is <5%, and it is always resistant to the current chemoradiotherapy. Therefore, new, effective agents for the treatment of pancreatic cancer are urgently needed. The promising strategy of cancer-targeting gene virotherapy (CTGVT) has demonstrated great anticancer potential. The objective of the current study was to determine whether 1 CTGVT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute-Phase Proteins
Share to Adenoviridae
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipocalin-2

Share to Lipocalins

Share to Oncolytic Virotherapy

Share to Pancreatic Neoplasms

Share to ras Proteins

Source

Identifiers

PMID: 22517373
DOI: 10.1002/cncr.27535

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene.PMID 22517373Read ↗

Oncolytic virotherapy for pancreatic cancer.Semantic proximity Read ↗

Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic VirusesSemantic proximity Read ↗

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and SolutionsSemantic proximity Read ↗

Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus.Semantic proximity Read ↗

Minute virus of mice is oncolytic for pancreatic cancer cells with mesenchymal phenotypeSemantic proximity Read ↗

Novel approaches to cancer therapy using oncolytic viruses.Semantic proximity Read ↗

Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus ImmunotherapySemantic proximity Read ↗

Gene therapy in pancreatic cancerSemantic proximity Read ↗

Oncolytic virotherapy as a novel strategy for pancreatic cancer.Semantic proximity Read ↗

Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironmentSemantic proximity Read ↗

Oncolytic Virotherapy for Cancer: Clinical ExperienceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.